Randomized clinical trial comparing 5% and 1% topical minoxidil for the treatment of androgenetic alopecia in Japanese men.
Quick navigation
Link to full study
http://www.ncbi.nlm.nih.gov/pubmed/19691748
Conclusion of this study
The difference between the groups was significant (P = 0.020). The incidence of adverse events was 8.7% (13/150) in the 5% group and 5.3% (8/150) in the 1% group, with no significant difference between the groups (chi(2)-test: P = 0.258). Our findings confirmed the superiority of 5% topical minoxidil to 1% topical minoxidil in treating Japanese men with androgenetic alopecia.
Supplements analyzed in this study
Health conditions analyzed in this study
Functions related to this study
Body systems related to this study